These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 3928589)
1. Saccharin induces morphological changes and enhances prolactin production in GH4C1 cells. Brennessel BA; Keyes KJ In Vitro Cell Dev Biol; 1985 Jul; 21(7):402-8. PubMed ID: 3928589 [TBL] [Abstract][Full Text] [Related]
2. Thyrotropin-releasing hormone and epidermal growth factor stimulate prolactin synthesis by a pathway(s) that differs from that used by phorbol esters: dissociation of actions by calcium dependency and additivity. Ramsdell JS; Tashjian AH Endocrinology; 1985 Nov; 117(5):2050-60. PubMed ID: 3930223 [TBL] [Abstract][Full Text] [Related]
3. Defective thyroliberin-induced prolactin synthesis and release in a hybrid GH strain. Brennessel BA; Biswas DK Mol Cell Biochem; 1984 Aug; 63(1):67-73. PubMed ID: 6092907 [TBL] [Abstract][Full Text] [Related]
4. Epidermal growth factor stimulates the prolactin synthesis and secretion in rat pituitary cells in culture (GH4C1 cells) by increasing the intracellular concentration of free calcium. Aanestad M; Røtnes JS; Torjesen PA; Haug E; Sand O; Bjøro T Acta Endocrinol (Copenh); 1993 Apr; 128(4):361-6. PubMed ID: 8388615 [TBL] [Abstract][Full Text] [Related]
5. Epidermal growth factor and thyrotropin-releasing hormone act similarly on a clonal pituitary cell strain. Modulation of hormone production and inhbition of cell proliferation. Schonbrunn A; Krasnoff M; Westendorf JM; Tashjian AH J Cell Biol; 1980 Jun; 85(3):786-97. PubMed ID: 6771298 [TBL] [Abstract][Full Text] [Related]
6. Role of specific protein kinase C isozymes in mediating epidermal growth factor, thyrotropin-releasing hormone, and phorbol ester regulation of the rat prolactin promoter in GH4/GH4C1 pituitary cells. Pickett CA; Manning N; Akita Y; Gutierrez-Hartmann A Mol Endocrinol; 2002 Dec; 16(12):2840-52. PubMed ID: 12456804 [TBL] [Abstract][Full Text] [Related]
7. Platelet-derived growth factor selectively decreases prolactin production in pituitary cells in culture. Sullivan NJ; Tashjian AH Endocrinology; 1983 Aug; 113(2):639-45. PubMed ID: 6223805 [TBL] [Abstract][Full Text] [Related]
8. Thyrotropin-releasing hormone rapidly stimulates a biphasic secretion of prolactin and growth hormone in GH4C1 rat pituitary tumor cells. Aizawa T; Hinkle PM Endocrinology; 1985 Jan; 116(1):73-82. PubMed ID: 3917255 [TBL] [Abstract][Full Text] [Related]
9. Transient dopaminergic inhibition of prolactin release from hybrid cells derived by fusion of normal rat pituitary and GH4C1 tumor cells. Day RN; Hinkle PM Endocrinology; 1988 May; 122(5):2165-73. PubMed ID: 3129281 [TBL] [Abstract][Full Text] [Related]
10. Induction (or stimulation) of prolactin and growth hormone production in a rat pituitary tumor cell line by bromodeoxyuridine. Cohen H; Andre J; Grenot C; Guillaumot P; Pascal O Endocrinology; 1982 Feb; 110(2):421-7. PubMed ID: 6799272 [TBL] [Abstract][Full Text] [Related]
11. Alpha-adrenergic inhibition of thyrotropin-releasing hormone-induced prolactin secretion in GH4C1 cells is associated with a depressed rise in intracellular Ca2+. Inukai T; Wang X; Greer MA Mol Cell Endocrinol; 1992 Sep; 87(1-3):29-34. PubMed ID: 1280233 [TBL] [Abstract][Full Text] [Related]
12. Bombesin stimulates prolactin and growth hormone release by pituitary cells in culture. Westendorf JM; Schonbrunn A Endocrinology; 1982 Feb; 110(2):352-8. PubMed ID: 6799271 [TBL] [Abstract][Full Text] [Related]
13. Epidermal growth factor induces prolactin mRNA in GH4C1 cells via a protein synthesis-dependent pathway. Gilchrist CA; Shull JD Mol Cell Endocrinol; 1993 Apr; 92(2):201-6. PubMed ID: 8391491 [TBL] [Abstract][Full Text] [Related]
14. Fibroblast growth factor-2 and epidermal growth factor modulate prolactin responses to TRH and dopamine in primary cultures. Spuch C; Diz-Chaves Y; Pérez-Tilve D; Mallo F Endocrine; 2006 Apr; 29(2):317-24. PubMed ID: 16785607 [TBL] [Abstract][Full Text] [Related]
15. Induction of hypothyroidism and hypoprolactinemia by growth hormone producing rat pituitary tumors. Seo H; Refetoff S; Fang VS Endocrinology; 1977 Jan; 100(1):216-26. PubMed ID: 401484 [TBL] [Abstract][Full Text] [Related]
16. Use of GH4C1 cell variants to demonstrate a non-spare receptor model for thyrotropin-releasing hormone action. Ramsdell JS; Tashjian AH Mol Cell Endocrinol; 1985 Dec; 43(2-3):173-80. PubMed ID: 3000850 [TBL] [Abstract][Full Text] [Related]
17. Regulation of thyroid hormone receptors and responses by thyrotropin-releasing hormone in GH4C1 cells. Kaji H; Hinkle PM Endocrinology; 1987 Nov; 121(5):1697-704. PubMed ID: 3117521 [TBL] [Abstract][Full Text] [Related]
18. GH4 pituitary cell variants selected as nonresponsive to thyrotropin-releasing hormone-enhanced substratum adhesion are nonresponsive to epidermal growth factor: evidence for a common signaling defect. Ramsdell JS; Tashjian AH J Cell Physiol; 1989 Dec; 141(3):565-72. PubMed ID: 2480354 [TBL] [Abstract][Full Text] [Related]
19. A permissive role for extracellular Ca2+ in regulation of prolactin production by 1,25-dihydroxyvitamin D3 in GH3 pituitary cells. Haug E; Bjøro T; Gautvik KM J Steroid Biochem; 1987 Oct; 28(4):385-91. PubMed ID: 2889849 [TBL] [Abstract][Full Text] [Related]
20. Effects of the protein tyrosine kinase inhibitor, herbimycin A, on prolactin gene expression in GH3 and 235-1 pituitary tumor cells. Billis WM; White BA Biochim Biophys Acta; 1997 Aug; 1358(1):31-8. PubMed ID: 9296518 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]